Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats

Authors: Wenhua Zhu, Siwen Chen, Ronggui Chen, Zhiqing Peng, Jun Wan, Benyan Wu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease, for which there is currently no safe and effective drug for therapy. In this study, we explored the effects of taurine, tea polyphenols (TPs), or a combination thereof, on NASH rats.

Methods

Rats were divided into a normal group, a high-fat diet induced model group and a treatment group (including taurine, TPs, or taurine + TPs treatment for 8 weeks). Twelve weeks later, all rats were sacrificed, and serum transaminase, lipid and lipopolysaccharide levels and hepatic oxidative stress levels were determined. Histological changes were evaluated.

Results

In NASH rats, hepatocyte damage, lipid disturbance, oxidative stress and elevated lipopolysaccharide levels were confirmed. Taurine treatment alleviated hepatocyte damage and oxidative stress. TPs treatment improved lipid metabolism and increased hepatic antioxidant activity. The therapeutic effects of taurine + TPs treatment on hepatocyte damage, lipid disturbance, and oxidative stress were superior to those of taurine and TPs treatment, respectively. Taurine, TPs and their combination all decreased serum lipopolysaccharide levels in NASH rats, but the combination of the compounds caused these levels to decrease more significantly than taurine or TPs treatment alone.

Conclusion

Taurine combined with TPs treatment could relieve NASH by alleviating hepatocyte damage, decreasing oxidative stress and improving lipid metabolism and gut flora disturbance partly. Taurine and TPs combination may act as a new effective medicine for treating NASH patients.
Literature
1.
go back to reference European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–1402. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–1402.
2.
go back to reference Fan JG, Farrell GC. Epidemiology of nonalcoholic fatty liver disease in china. J Hepatol. 2009;50:204–10.CrossRefPubMed Fan JG, Farrell GC. Epidemiology of nonalcoholic fatty liver disease in china. J Hepatol. 2009;50:204–10.CrossRefPubMed
3.
go back to reference Bril F, Cusi K. Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus. Endocrinol Metab Clin N Am. 2016;45:765–81.CrossRef Bril F, Cusi K. Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus. Endocrinol Metab Clin N Am. 2016;45:765–81.CrossRef
4.
go back to reference Perazzo H, Dufour JF. The therapeutic landscape of non-alcoholic steatohepatitis. Liver Int. 2017;37:634–47.CrossRefPubMed Perazzo H, Dufour JF. The therapeutic landscape of non-alcoholic steatohepatitis. Liver Int. 2017;37:634–47.CrossRefPubMed
5.
go back to reference Chen YX, Liu S, Zeng X, Xie WF. A pilot study of the effect of taurine on patients with nonalcoholic fatty liver. Chin J Pract Intern Med. 2005;25:249–50. Chen YX, Liu S, Zeng X, Xie WF. A pilot study of the effect of taurine on patients with nonalcoholic fatty liver. Chin J Pract Intern Med. 2005;25:249–50.
6.
go back to reference Chen S-W, Chen Y-X, Shi J, Lin Y, Xie W-F. The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig Dis Sci. 2006;51:2225–34.CrossRefPubMed Chen S-W, Chen Y-X, Shi J, Lin Y, Xie W-F. The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig Dis Sci. 2006;51:2225–34.CrossRefPubMed
7.
go back to reference Gentile CL, Nivala AM, Gonzales JC, Pfaffenbach KT, Wang D, Wei F, et al. Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol. 2011;301:R1710–22.CrossRefPubMedPubMedCentral Gentile CL, Nivala AM, Gonzales JC, Pfaffenbach KT, Wang D, Wei F, et al. Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol. 2011;301:R1710–22.CrossRefPubMedPubMedCentral
8.
go back to reference Zeng X, Lin Y, Sheng X, Wang Y, Chen Y, Xie W, et al. Combination of taurine with silybin meglumine in treatment of patients with non-alcohlic steatohepatitis. Chin J Digest. 2010;30:441–3. Zeng X, Lin Y, Sheng X, Wang Y, Chen Y, Xie W, et al. Combination of taurine with silybin meglumine in treatment of patients with non-alcohlic steatohepatitis. Chin J Digest. 2010;30:441–3.
9.
go back to reference Tenore GC, Daglia M, Ciampaglia R, Novellino E. Exploring the nutraceutical potential of polyphenols from black, green and white tea infusions - an overview. Curr Pharm Biotechnol. 2015;16:265–71.CrossRefPubMed Tenore GC, Daglia M, Ciampaglia R, Novellino E. Exploring the nutraceutical potential of polyphenols from black, green and white tea infusions - an overview. Curr Pharm Biotechnol. 2015;16:265–71.CrossRefPubMed
10.
go back to reference Murakami A. Dose-dependent functionality and toxicity of green tea polyphenols in experimental rodents. Arch Biochem Biophys. 2014;557:3–10.CrossRefPubMed Murakami A. Dose-dependent functionality and toxicity of green tea polyphenols in experimental rodents. Arch Biochem Biophys. 2014;557:3–10.CrossRefPubMed
11.
go back to reference Lambert JD, Kim DH, Zheng R, Yang CS. Transdermal delivery of (−)-epigallocatechin-3-gallate, a green tea polyphenol, in mice. J Pharm Pharmacol. 2006;58:599–604.CrossRefPubMed Lambert JD, Kim DH, Zheng R, Yang CS. Transdermal delivery of (−)-epigallocatechin-3-gallate, a green tea polyphenol, in mice. J Pharm Pharmacol. 2006;58:599–604.CrossRefPubMed
12.
13.
go back to reference Tommasino E, Griffa S, Grunberg K, Ribotta A, Colomba EL, Carloni E, et al. Malondialdehyde content as a potential biochemical indicator of tolerant Cenchrus Ciliaris L. genotypes under heat stress treatment. Grass Forage Sci. 2012;67:456–9.CrossRef Tommasino E, Griffa S, Grunberg K, Ribotta A, Colomba EL, Carloni E, et al. Malondialdehyde content as a potential biochemical indicator of tolerant Cenchrus Ciliaris L. genotypes under heat stress treatment. Grass Forage Sci. 2012;67:456–9.CrossRef
14.
go back to reference Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836–46.CrossRefPubMed Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836–46.CrossRefPubMed
15.
16.
go back to reference Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, Allemand H. Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia. 2012;55:1953–62.CrossRefPubMedPubMedCentral Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, Allemand H. Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia. 2012;55:1953–62.CrossRefPubMedPubMedCentral
17.
go back to reference Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer the selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2011;306:1549–56.CrossRefPubMedPubMedCentral Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer the selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2011;306:1549–56.CrossRefPubMedPubMedCentral
18.
go back to reference Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010;341:c5702.CrossRefPubMedPubMedCentral Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010;341:c5702.CrossRefPubMedPubMedCentral
19.
go back to reference Aqel B, DiBaise JK. Role of the gut microbiome in nonalcoholic fatty liver disease. Nutr Clin Pract. 2015;30:780–6.CrossRefPubMed Aqel B, DiBaise JK. Role of the gut microbiome in nonalcoholic fatty liver disease. Nutr Clin Pract. 2015;30:780–6.CrossRefPubMed
20.
go back to reference Tabibian JH, Varghese C, LaRusso NF, O'Hara SP. The enteric microbiome in hepatobiliary health and disease. Liver Int. 2016;36:480–7.PubMed Tabibian JH, Varghese C, LaRusso NF, O'Hara SP. The enteric microbiome in hepatobiliary health and disease. Liver Int. 2016;36:480–7.PubMed
21.
go back to reference Alisi A, Manco M, Devito R, Piemonte F, Nobili V. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2010;50:645–9.CrossRefPubMed Alisi A, Manco M, Devito R, Piemonte F, Nobili V. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2010;50:645–9.CrossRefPubMed
22.
go back to reference Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010;7:15.CrossRef Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010;7:15.CrossRef
23.
go back to reference Aller R, De Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci. 2011;15:1090–5.PubMed Aller R, De Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci. 2011;15:1090–5.PubMed
24.
go back to reference Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC, et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol. 2013;12:256–62.PubMed Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC, et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol. 2013;12:256–62.PubMed
25.
go back to reference Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 2011;300:G433–41.CrossRefPubMedPubMedCentral Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 2011;300:G433–41.CrossRefPubMedPubMedCentral
26.
go back to reference Gkolfakis P, Dimitriadis G, Triantafyllou K. Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2015;14:572–81.CrossRefPubMed Gkolfakis P, Dimitriadis G, Triantafyllou K. Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2015;14:572–81.CrossRefPubMed
27.
go back to reference Wan ML, Ling KH, Wang MF, El-Nezami H. Green tea polyphenol epigallocatechin-3-gallate improves epithelial barrier function by inducing the production of antimicrobial peptide pBD-1 and pBD-2 in monolayers of porcine intestinal epithelial IPEC-J2 cells. Mol Nutr Food Res. 2016;60:1048–58.CrossRefPubMed Wan ML, Ling KH, Wang MF, El-Nezami H. Green tea polyphenol epigallocatechin-3-gallate improves epithelial barrier function by inducing the production of antimicrobial peptide pBD-1 and pBD-2 in monolayers of porcine intestinal epithelial IPEC-J2 cells. Mol Nutr Food Res. 2016;60:1048–58.CrossRefPubMed
28.
go back to reference Wessner B, Strasser EM, Koitz N, Schmuckenschlager C, Unger-Manhart N, Roth E. Green tea polyphenol administration partly ameliorates chemotherapy-induced side effects in the smallintestine of mice. J Nutr. 2007;137:634–40.PubMed Wessner B, Strasser EM, Koitz N, Schmuckenschlager C, Unger-Manhart N, Roth E. Green tea polyphenol administration partly ameliorates chemotherapy-induced side effects in the smallintestine of mice. J Nutr. 2007;137:634–40.PubMed
29.
go back to reference Muià C, Mazzon E, Di Paola R, Genovese T, Menegazzi M, Caputi AP, et al. Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut. Naunyn Schmiedeberg's Arch Pharmacol. 2005;371:364–74.CrossRef Muià C, Mazzon E, Di Paola R, Genovese T, Menegazzi M, Caputi AP, et al. Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut. Naunyn Schmiedeberg's Arch Pharmacol. 2005;371:364–74.CrossRef
30.
go back to reference Sukhotnik I, Aranovich I, Ben Shahar Y, Bitterman N, Pollak Y, Berkowitz D, et al. Effect of taurine on intestinal recovery following intestinal ischemia-reperfusion injury in a rat. Pediatr Surg Int. 2016;32:161–8.CrossRefPubMed Sukhotnik I, Aranovich I, Ben Shahar Y, Bitterman N, Pollak Y, Berkowitz D, et al. Effect of taurine on intestinal recovery following intestinal ischemia-reperfusion injury in a rat. Pediatr Surg Int. 2016;32:161–8.CrossRefPubMed
31.
go back to reference Al-Asmari AK, Al-Zahrani AM, Khan AQ, Al-Shahrani HM, Ali Al Amri M. Taurine ameliorates 5-flourouracil-induced intestinal mucositis, hepatorenal and reproductive organ damage in Wistar rats: A biochemical and histological study. Hum Exp Toxicol. 2016;35:10–20.CrossRefPubMed Al-Asmari AK, Al-Zahrani AM, Khan AQ, Al-Shahrani HM, Ali Al Amri M. Taurine ameliorates 5-flourouracil-induced intestinal mucositis, hepatorenal and reproductive organ damage in Wistar rats: A biochemical and histological study. Hum Exp Toxicol. 2016;35:10–20.CrossRefPubMed
Metadata
Title
Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats
Authors
Wenhua Zhu
Siwen Chen
Ronggui Chen
Zhiqing Peng
Jun Wan
Benyan Wu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1961-3

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue